Design, fabrication and perivascular implantation of bioactive scaffolds engineered with human adventitial progenitor cells for stimulation of arteriogenesis in peripheral ischemia

Published in Biofabrication, vol. 8(1), art. 015020 (2016) · IOP Publishing
DOI: 10.1088/1758-5090/8/1/015020

Summary

Cell therapy is a promising way to restore blood supply to ischemic tissue, but simply injecting loose cells rarely delivers them precisely to the recipient’s vasculature. Wrapping a cell-engineered scaffold around the blocked artery could overcome this. Here the authors fabricate 3D woodpile- and channel-shaped scaffolds from polycaprolactone (PCL) using a computer-assisted pressure-assisted micro-syringe writing system, then coat them with electrospun gelatin nanofibers. The composite scaffolds were seeded with human adventitial progenitor cells (APCs) isolated from saphenous-vein surgical leftovers; channel-shaped, GPTMS-crosslinked scaffolds gave the best cell alignment, survival and growth. When implanted around the femoral artery of mice with limb ischemia, these scaffolds — with or without APCs — accelerated recovery of limb blood flow and boosted arteriogenesis, pointing to perivascular cell-engineered scaffolds as a therapeutic route for peripheral ischemia.

Authors & Affiliations

Topics

Vascular Tissue Engineering Cell-Seeded Scaffolds Arteriogenesis Limb Ischemia

Materials

Polycaprolactone (PCL) Gelatin

Linari Electrospinning Systems

Electrospinning machines by Linari Nanotech
Linari Nanotech designs and manufactures electrospinning systems for nanofiber research and production — including gelatin nanofibre coatings on 3D scaffolds for vascular tissue engineering.
Read the full publication
Back to blog